$MRNA just reminded me how crazy biotech can get. After years of being written off following its fall from $484, Moderna jumped 176.97% to $174.38 in ONE day after positive Phase 3 results for its personalized mRNA cancer treatment with Merck’s Keytruda. The trial hit key endpoints in high-risk melanoma. The treatment still needs approval, but this is a huge milestone. Moves like this are why I keep an eye on biotech. If you want to trade the move, $MRNA/USDT Perpetual is available on BingX. $ETH #Macro Insights# #Altcoin Season#